Mutations of the Smad4 gene in acute myelogeneous leukemia and their functional implications in leukemogenesis
Open Access
- 4 January 2001
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 20 (1), 88-96
- https://doi.org/10.1038/sj.onc.1204057
Abstract
The Smad family proteins are critical components of the transforming growth factor (TGF)-β signaling pathway. TGF-β is a multipotent cytokine that elicits many biological functions. In particular, TGF-β exhibits effects on the cell cycle manifested by G1-phase arrest, differentiation, or apoptosis of several target cells, suggesting that disruption of TGF-β signaling pathway could be involved in cancer formation. Here we show one missense mutation of the Smad4 gene in the MH1 domain (P102L) and one frame shift mutation resulting in termination in the MH2 domain (Δ(483–552)) in acute myelogeneous leukemia. Both of the mutated Smad4 proteins lack transcriptional activities. Concomitant expression of the P102L mutant with wild-type Smad4 inactivates wild-type Smad4 through inhibiting its DNA-binding ability. The Δ(483–552) mutant blocks nuclear translocation of wild-type Smad4 and thus disrupts TGF-β signaling. This is the first report showing that mutations in the Smad4 gene are associated with the pathogenesis of acute myelogeneous leukemia and the obtained results should provide useful insights into the mechanism whereby disruption of TGF-β signaling pathway could lead to acute myelogeneous leukemia.This publication has 35 references indexed in Scilit:
- Cooperative Binding of Smad Proteins to Two Adjacent DNA Elements in the Plasminogen Activator Inhibitor-1 Promoter Mediates Transforming Growth Factor β-induced Smad-dependent Transcriptional ActivationJournal of Biological Chemistry, 1999
- TLE, the Human Homolog of Groucho, Interacts with AML1 and Acts as a Repressor of AML1-Induced TransactivationBiochemical and Biophysical Research Communications, 1998
- TGF-β SIGNAL TRANSDUCTIONAnnual Review of Biochemistry, 1998
- Human Smad3 and Smad4 Are Sequence-Specific Transcription ActivatorsMolecular Cell, 1998
- Dual role of the Smad4/DPC4 tumor suppressor in TGFβ-inducible transcriptional complexesGenes & Development, 1997
- Partnership between DPC4 and SMAD proteins in TGF-β signalling pathwaysNature, 1996
- Receptor-associated Mad homologues synergize as effectors of the TGF-β responseNature, 1996
- DPC4 , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1Science, 1996
- Mechanism of activation of the TGF-β receptorNature, 1994
- Two forms of transforming growth factor-β distinguished by multipotential haematopoietic progenitor cellsNature, 1987